Decipher Bladder Cancer Genomic Profiling
Bladder cancer is the fourth most common cancer in males and the risk of developing bladder cancer is 4-5 fold greater in males than in females. Initially, benign tumor(s) arise within the bladder lining or deep tissue which later undergo malignant transformation and may metastasize. Clinical findings include hematuria, lower back pain along with frequent and painful urination. The major cause of bladder cancers is germline mutations in FGFR3, PIK3CA, KDM6A, or TP53. Decipher bladder cancer genomic profiling allows comprehensive and accurate diagnosis of bladder cancers along with subtype specification.
Various studies have shown that utilization of the Decipher assay generated more accurate and easy results as compared to individual genetic testing. It is a molecular profiling test that uses gene expression analysis from bladder cancer specimens obtained by transurethral resection. The cancer is classified into 4 subtypes: luminal, luminal-infiltrated, basal, and neuroendocrine-like. Each of these subtypes is found to have a distinct biological pattern. Decipher assay is highly indicated for patients considering neoadjuvant chemotherapy (NAC). The assay is capable to predict the survival benefit from NAC in bladder cancer patients. The company claims that the Decipher assay aids clinicians in the decision whether to immediately proceed the patient to cystectomy or follow NAC for the better survival of the patient.
Although, numerous tests and test panels for diagnosing bladder have been developed that utilize DNA (Urovysion FISH), RNA (Cxbladder test, Xpert Bladder Cancer Monitor), protein antigens (Complement factor H), and/or nuclear matrix proteins (NMP22, BLCA-4, BLCA-1), none of these are currently recommended by the NCCN or major societies for screening or diagnosis of bladder cancer as a replacement for cystoscopy and biopsy.
Normal, no cancer found
Trans-urethral resection of bladder tumor (TURBT).
Formalin-fixed, paraffin-embedded tissue.
Stability
- Formalin-fixed, paraffin-embedded tissue are stable at room temperature for longer.
- Curr Opin Urol. 2019; 6:350-356 [PMID: 31158107]
- Eur Urol. 2017; 10:544-554 [PMID: 28390739]
- Rev Urol. 2016; 1:1-9 [PMID: 27162506]
- J Clin Oncol. 2017 Jun 20;35(18):1991-1998. [PMID: 28358655]
- https://decipherbio.com/bladder/